Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedEnrollment site update: Fargo, North Dakota (58102) was added as a current site, while the Fargo, North Dakota (58122) site was removed. The page revision has been updated to version 3.5.0.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3, indicating an internal update.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision label on the page updated from v3.4.1 to v3.4.2, replacing the previous version.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.4.1 was added and revision: v3.4.0 was removed. This appears to be a backend/UI version update with no visible changes to the study details.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision metadata updated from v3.3.3 to v3.3.4. This appears to be a minor version update with no changes to the study content, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check101 days agoChange DetectedLocations section updated: Colorado, Massachusetts, New York, North Dakota, Ohio, South Dakota, and Texas are listed; corresponding state location entries were removed. Revision tag updated from v3.3.2 to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.